Report overview
Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation.
This report contains market size and forecasts of Epoprostenol Sodium Drugs in global, including the following market information:
Global Epoprostenol Sodium Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Epoprostenol Sodium Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Epoprostenol Sodium Drugs companies in 2021 (%)
The global Epoprostenol Sodium Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.5 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epoprostenol Sodium Drugs include GSK and Teva etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Epoprostenol Sodium Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epoprostenol Sodium Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epoprostenol Sodium Drugs Market Segment Percentages, by Type, 2021 (%)
0.5 mg
1.5 mg
Global Epoprostenol Sodium Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epoprostenol Sodium Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Epoprostenol Sodium Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epoprostenol Sodium Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epoprostenol Sodium Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Epoprostenol Sodium Drugs revenues share in global market, 2021 (%)
Key companies Epoprostenol Sodium Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Epoprostenol Sodium Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Teva
